Total Payments
$1,710
2018 Payments
$416.45
Companies
10
Transactions
65
Medicare Patients
5,394
Medicare Billing
$788,183
Payment Breakdown by Category
Food & Beverage$1,600 (93.6%)
Education$110.13 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,600 | 62 | 93.6% |
| Education | $110.13 | 3 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $746.22 | 29 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $502.87 | 13 | $0 (2018) |
| Shire North American Group Inc | $158.20 | 10 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $133.94 | 3 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $87.20 | 2 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $25.49 | 4 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $20.45 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.12 | 1 | $0 (2018) |
| Lundbeck LLC | $11.68 | 1 | $0 (2017) |
| Vanda Pharmaceuticals Inc. | $11.63 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $416.45 | 20 | Shire North American Group Inc ($158.20) |
| 2017 | $1,293 | 45 | Allergan Inc. ($701.74) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2018 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $76.25 | General |
| 10/29/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/08/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/26/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/05/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2018 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug), Fanapt | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 05/01/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $98.04 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/12/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $107.25 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/16/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/15/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/18/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $137.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2017 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,159 | 2,546 | $388,837 | $167,250 |
| 2022 | 13 | 1,315 | 3,113 | $474,077 | $194,496 |
| 2021 | 11 | 1,332 | 3,051 | $457,173 | $192,679 |
| 2020 | 11 | 1,588 | 3,636 | $545,625 | $233,758 |
Total Patients
5,394
Total Services
12,346
Medicare Billing
$788,183
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 433 | 1,051 | $131,375 | $55,485 | 42.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 521 | $78,150 | $31,619 | 40.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 163 | 249 | $37,350 | $19,443 | 52.1% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 159 | 159 | $36,570 | $15,094 | 41.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 127 | $26,035 | $11,544 | 44.3% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 40 | 132 | $23,892 | $11,268 | 47.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 66 | 66 | $15,180 | $6,721 | 44.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 56 | 58 | $13,050 | $5,814 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 46 | $6,900 | $2,465 | 35.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 22 | 55 | $7,700 | $2,321 | 30.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 41 | $6,150 | $2,316 | 37.7% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 17 | 17 | $3,485 | $1,799 | 51.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 24 | 24 | $3,000 | $1,362 | 45.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 487 | 1,392 | $174,000 | $69,551 | 40.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 59 | 499 | $74,850 | $27,433 | 36.7% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 69 | 241 | $44,585 | $22,625 | 50.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 179 | 280 | $42,000 | $18,747 | 44.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 163 | 166 | $38,180 | $15,618 | 40.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 60 | 111 | $22,755 | $8,774 | 38.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 82 | 82 | $18,860 | $7,926 | 42.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 62 | 68 | $15,300 | $7,107 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 78 | $11,700 | $4,599 | 39.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 30 | 89 | $12,460 | $4,205 | 33.7% |
| 99326 | New patient custodial care facility, group care, or assisted living visit, typically 45 minutes | Office | 2022 | 24 | 24 | $5,592 | $2,340 | 41.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 21 | $4,515 | $1,805 | 40.0% |
About Dr. Michael Dayem, M.D
Dr. Michael Dayem, M.D is a Psychiatry healthcare provider based in Garfield Heights, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255323432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dayem, M.D has received a total of $1,710 in payments from pharmaceutical and medical device companies, with $416.45 received in 2018. These payments were reported across 65 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,600).
As a Medicare-enrolled provider, Dayem has provided services to 5,394 Medicare beneficiaries, totaling 12,346 services with total Medicare billing of $788,183. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Garfield Heights, OH
- Active Since 08/16/2005
- Last Updated 04/26/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1255323432
Products in Payments
- VRAYLAR (Drug) $544.14
- NUPLAZID (Drug) $502.87
- NAMZARIC (Drug) $181.80
- MYDAYIS (Drug) $143.68
- REXULTI (Drug) $135.69
- Trintellix (Drug) $37.61
- LATUDA (Drug) $20.45
- LINZESS (Drug) $20.28
- VYVANSE (Drug) $14.52
- Hetlioz (Drug) $11.63
- AUSTEDO (Drug) $10.95
- ABILIFY MAINTENA (Drug) $9.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Garfield Heights
Byung Jinn, Md, MD
Psychiatry — Payments: $443.69
Psychiatry $443.69
Dr. Stephen Ferber, M.d, M.D
Psychiatry — Payments: $347.97
Psychiatry $347.97
Jung El-Mallawany, Md, MD
Psychiatry — Payments: $113.56
Psychiatry $113.56
Yolanda Ganchorre, Md, MD
Psychiatry
Psychiatry
Dr. Margot Quinn, Md, MD
Psychiatry
Psychiatry